Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 11 04:00PM ET
108.73
Dollar change
-1.91
Percentage change
-1.73
%
Index- P/E- EPS (ttm)-2.15 Insider Own0.26% Shs Outstand237.73M Perf Week-0.22%
Market Cap25.85B Forward P/E- EPS next Y-3.66 Insider Trans0.00% Shs Float237.11M Perf Month-9.78%
Income-501.56M PEG- EPS next Q0.70 Inst Own17.98% Short Float1.02% Perf Quarter31.25%
Sales3.30B P/S7.83 EPS this Y-182.46% Inst Trans0.12% Short Ratio2.46 Perf Half Y17.27%
Book/sh88.98 P/B1.22 EPS next Y-8.84% ROA-2.07% Short Interest2.41M Perf Year9.47%
Cash/sh78.44 P/C1.39 EPS next 5Y- ROE-2.37% 52W Range76.53 - 131.49 Perf YTD3.02%
Dividend Est.- P/FCF17.48 EPS past 5Y- ROI-2.33% 52W High-17.31% Beta0.20
Dividend TTM- Quick Ratio7.21 Sales past 5Y843.27% Gross Margin84.31% 52W Low42.07% ATR (14)4.20
Dividend Ex-DateJun 02, 2022 Current Ratio7.33 EPS Y/Y TTM-118.03% Oper. Margin-8.08% RSI (14)43.95 Volatility4.16% 3.21%
Employees3082 Debt/Eq0.01 Sales Y/Y TTM-52.11% Profit Margin-15.20% Recom1.68 Target Price138.45
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q22.07% Payout0.00% Rel Volume1.43 Prev Close110.64
Sales Surprise141.90% EPS Surprise152.75% Sales Q/Q40.41% EarningsNov 04 BMO Avg Volume982.56K Price108.73
SMA20-2.78% SMA50-3.14% SMA20014.04% Trades Volume1,406,541 Change-1.73%
Date Action Analyst Rating Change Price Target Change
Nov-08-24Upgrade Goldman Neutral → Buy $90 → $137
Sep-24-24Upgrade Morgan Stanley Equal-Weight → Overweight $93 → $145
Sep-17-24Upgrade Jefferies Hold → Buy $96 → $150
Sep-16-24Upgrade JP Morgan Underweight → Neutral $91 → $125
Aug-07-24Upgrade Deutsche Bank Hold → Buy $95
Aug-02-24Upgrade HSBC Securities Hold → Buy
May-14-24Initiated Evercore ISI In-line $100
Feb-23-24Initiated BMO Capital Markets Outperform $127
Jan-05-24Initiated Oppenheimer Perform
Dec-01-23Downgrade JP Morgan Neutral → Underweight $106 → $99
Nov-09-24 02:12PM
Nov-06-24 01:15PM
Nov-05-24 07:17AM
07:17AM
03:28AM
02:02AM Loading…
02:02AM
12:10AM
Nov-04-24 06:39PM
04:04PM
02:15PM
09:41AM
08:56AM
07:07AM
06:45AM
Oct-31-24 07:45AM
03:49PM Loading…
Oct-29-24 03:49PM
Oct-23-24 04:00AM
Oct-21-24 03:44PM
12:51PM
07:40AM
06:45AM
Oct-18-24 04:14PM
10:25AM
Oct-16-24 06:59AM
Oct-14-24 11:13PM
Oct-08-24 05:50AM
Oct-07-24 01:00PM
Oct-01-24 06:00AM
Sep-25-24 11:13AM
Sep-20-24 08:11AM
12:02PM Loading…
Sep-19-24 12:02PM
05:12AM
Sep-17-24 04:09PM
06:45AM
04:24AM
Sep-13-24 06:41PM
09:34AM
06:12AM
Sep-05-24 07:15AM
Sep-04-24 09:15AM
08:30AM
Aug-26-24 06:52AM
Aug-23-24 02:01PM
Aug-22-24 02:33PM
02:15PM
01:44PM
Aug-21-24 12:12AM
Aug-20-24 05:52AM
Aug-19-24 09:39AM
08:05AM
04:07AM
Aug-16-24 11:12PM
04:21PM
04:08PM
01:29PM
10:21AM
08:20AM
06:45AM
Aug-13-24 02:43PM
Aug-08-24 06:40AM
Aug-05-24 02:30PM
01:24PM
11:53AM
10:28AM
07:59AM
06:02AM
05:59AM
Jul-30-24 06:52AM
06:45AM
Jul-24-24 06:33AM
Jul-22-24 06:45AM
Jul-02-24 08:00AM
Jul-01-24 11:00PM
12:34PM
12:19PM
Jun-28-24 04:32AM
Jun-27-24 10:30AM
Jun-24-24 06:45AM
Jun-18-24 11:53AM
10:19AM
Jun-17-24 11:50AM
Jun-03-24 03:41PM
09:17AM
04:45AM
Jun-01-24 10:00AM
May-31-24 07:15AM
May-30-24 04:25AM
May-29-24 08:00AM
May-26-24 08:00PM
May-24-24 12:16PM
08:15AM
May-21-24 06:45AM
04:00AM
May-20-24 02:09PM
May-18-24 02:42AM
May-17-24 02:46PM
01:17PM
12:36PM
11:15AM
May-14-24 07:58AM
BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ATHOS KG10% OwnerOct 16 '24Proposed Sale117.748,036946,154Oct 16 05:03 PM
ATHOS KG10% OwnerOct 14 '24Proposed Sale120.8325,4243,071,964Oct 15 08:41 AM
ATHOS KG10% OwnerOct 11 '24Proposed Sale120.1340,0004,805,228Oct 11 04:15 PM
ATHOS KG10% OwnerOct 10 '24Proposed Sale117.4720,0002,349,436Oct 10 04:13 PM
ATHOS KG10% OwnerOct 09 '24Proposed Sale119.066,000714,361Oct 09 04:02 PM
ATHOS KG10% OwnerOct 08 '24Proposed Sale122.0115,0001,830,100Oct 08 04:24 PM
ATHOS KG10% OwnerOct 04 '24Proposed Sale122.8014,7561,812,078Oct 04 04:17 PM
ATHOS KG10% OwnerOct 03 '24Proposed Sale119.2750,0005,963,585Oct 03 05:14 PM
ATHOS KG10% OwnerOct 02 '24Proposed Sale119.0465,2007,761,193Oct 02 06:18 PM
ATHOS KG10% OwnerOct 01 '24Proposed Sale119.2472,0868,595,657Oct 01 04:18 PM
ATHOS KG10% OwnerSep 30 '24Proposed Sale118.2276,1148,998,197Sep 30 04:52 PM
ATHOS KG10% OwnerSep 27 '24Proposed Sale117.6437,2044,376,679Sep 27 05:12 PM
ATHOS KG10% OwnerSep 25 '24Proposed Sale118.4737,9434,495,107Sep 25 07:14 PM
ATHOS KG10% OwnerSep 18 '24Proposed Sale124.7155,6056,934,500Sep 18 07:28 PM
ATHOS KG10% OwnerSep 17 '24Proposed Sale124.4930,1623,754,792Sep 17 04:14 PM
ATHOS KG10% OwnerSep 16 '24Proposed Sale123.40500,00061,700,000Sep 16 05:35 PM
ATHOS KG10% OwnerSep 16 '24Proposed Sale126.0290,00011,341,611Sep 16 04:12 PM
ATHOS KG10% OwnerSep 13 '24Proposed Sale115.02170,00019,552,584Sep 13 04:12 PM